BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11811112)

  • 1. [Galstena efficacy in patients with biliary dyskinesia, chronic cholecystitis and cholelithiasis].
    Grigor'eva IN; Shabalin AV; Tikhonov AV; Moiseenko EE; Ragino IuI
    Klin Med (Mosk); 2001; 79(11):52-4. PubMed ID: 11811112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic cholecystitis--some lithogenic aspects].
    Osadchuk MA; Geras'kina TB
    Ter Arkh; 1997; 69(2):27-30. PubMed ID: 9173571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis].
    Il'chenko AA; Drozhzhina IuV
    Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Galstena therapy of some hepatobiliary diseases].
    Munushkin ON
    Klin Med (Mosk); 2001; 79(12):38-41. PubMed ID: 11840810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correction of disorders of lipid-mineral composition of the bile as a method for preventing cholelithiasis].
    Lukash NV; Krutikov SN; Finiotu GA; Serbest AR
    Vrach Delo; 1990 Jan; (1):14-7. PubMed ID: 2330698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 7. [New approaches to cholelithiasis prevention in young patients].
    Volevach LV
    Vestn Ross Akad Med Nauk; 2005; (11):24-7. PubMed ID: 16408649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biliary calculosis, cholesterosis of the gallbladder, xanthogranulematous cholecystitis: clinical-morphological parallels].
    Shcherbinina MB; Zakrevskaia EV
    Ter Arkh; 2008; 80(2):66-71. PubMed ID: 18372600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A choice of optimal vegetotropic pharmacotherapy in patients with chronic non-calculous cholecystitis in combination with dyskinesia of the gallbladder].
    Fedorov NE; Nemtsov LM; Shchuko AG; Mishchuk IF; Belgorodtseva RI
    Eksp Klin Gastroenterol; 2002; (2):76-9, 103. PubMed ID: 12046393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alkaline phosphatase of the bile as a criterion of biliary tract inflammation].
    Tsudik AZ; Asadov NK; Astsaturova GN
    Vopr Med Khim; 1986; 32(4):24-7. PubMed ID: 3765495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of dyspeptic disorders, lithiasis and biliary dyskinesia with ursodeoxycholic acid. Analysis of a controlled multicenter study].
    Realini S; Reiner M; Frigerio G
    Schweiz Med Wochenschr; 1980 May; 110(22):879-80. PubMed ID: 6996086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of biliary tract dyskinesia and inflammation in viral hepatitis].
    Andreĭchin MA; Kiĭko LG
    Vrach Delo; 1983 May; (5):112-5. PubMed ID: 6880156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of the preparation Verbascan in treating gastrointestinal and biliary diseases].
    Dimitrov B; Mendizova A; Brailski Kh; Ivanov L; Bozhiianov V
    Vutr Boles; 1983; 22(1):18-24. PubMed ID: 6356605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phytotherapy in digestive organ diseases].
    Kukharenko OM
    Vrach Delo; 1991 Sep; (9):82-7. PubMed ID: 1759441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bile excretion system in endogenous hypercorticism syndrome].
    German SV; Lemeshko ZA; Vaĭnshteĭn TIa; Petrova EA
    Sov Med; 1989; (3):15-9. PubMed ID: 2734666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bile duct diseases. Dyskinesias. Chronic inflammation].
    Pontes JF; Tacla M
    Arq Gastroenterol; 1981; 18(4):156-61. PubMed ID: 6751300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Archman health resort factors on the bile chemistry of chronic cholecystitis patients].
    Khodzhakuliev GK; Ovezova GK
    Ter Arkh; 1986; 58(2):100-2. PubMed ID: 2939582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of tykveol in the treatment of impaired biliary tract function in patients with chronic non-calculous cholecystitis].
    Vakhrushev IaM; Petrova LI
    Klin Med (Mosk); 2004; 82(10):49-51. PubMed ID: 15584601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biliary tract function in chronic cholecystitis patients during treatment].
    Bereza NM
    Vrach Delo; 1984 Jul; (7):24-7. PubMed ID: 6475013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basis for the use of a new galena-based substance from plants for prevention and treatment of cholelithic disease].
    Bogdarin IuA; Bundin DV
    Eksp Klin Gastroenterol; 2003; (3):47-9, 117. PubMed ID: 14556547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.